Tissue repair, contraction, and the myofibroblast

After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the fibroblast and the smooth muscle cell, the myofibroblast has been identified both in normal tissues, particularly in locations where there is a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Wound repair and regeneration Ročník 13; číslo 1; s. 7 - 12
Hlavní autoři: Desmoulière, Alexis, Chaponnier, Christine, Gabbiani, Giulio
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.01.2005
Témata:
ISSN:1067-1927
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the fibroblast and the smooth muscle cell, the myofibroblast has been identified both in normal tissues, particularly in locations where there is a necessity of mechanical force development, and in pathological tissues, in relation with hypertrophic scarring, fibromatoses and fibrocontractive diseases as well as in the stroma reaction to epithelial tumors. It is now accepted that fibroblast/myofibroblast transition begins with the appearance of the protomyofibroblast, whose stress fibers contain only beta- and gamma-cytoplasmic actins and evolves, but not necessarily always, into the appearance of the differentiated myofibroblast, the most common variant of this cell, with stress fibers containing alpha-smooth muscle actin. Myofibroblast differentiation is a complex process, regulated by at least a cytokine (the transforming growth factor-beta1), an extracellular matrix component (the ED-A splice variant of cellular fibronectin), as well as the presence of mechanical tension. The myofibroblast is a key cell for the connective tissue remodeling that takes place during wound healing and fibrosis development. On this basis, the myofibroblast may represent a new important target for improving the evolution of such diseases as hypertrophic scars, and liver, kidney or pulmonary fibrosis.
AbstractList After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the fibroblast and the smooth muscle cell, the myofibroblast has been identified both in normal tissues, particularly in locations where there is a necessity of mechanical force development, and in pathological tissues, in relation with hypertrophic scarring, fibromatoses and fibrocontractive diseases as well as in the stroma reaction to epithelial tumors. It is now accepted that fibroblast/myofibroblast transition begins with the appearance of the protomyofibroblast, whose stress fibers contain only beta- and gamma-cytoplasmic actins and evolves, but not necessarily always, into the appearance of the differentiated myofibroblast, the most common variant of this cell, with stress fibers containing alpha-smooth muscle actin. Myofibroblast differentiation is a complex process, regulated by at least a cytokine (the transforming growth factor-beta1), an extracellular matrix component (the ED-A splice variant of cellular fibronectin), as well as the presence of mechanical tension. The myofibroblast is a key cell for the connective tissue remodeling that takes place during wound healing and fibrosis development. On this basis, the myofibroblast may represent a new important target for improving the evolution of such diseases as hypertrophic scars, and liver, kidney or pulmonary fibrosis.After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the fibroblast and the smooth muscle cell, the myofibroblast has been identified both in normal tissues, particularly in locations where there is a necessity of mechanical force development, and in pathological tissues, in relation with hypertrophic scarring, fibromatoses and fibrocontractive diseases as well as in the stroma reaction to epithelial tumors. It is now accepted that fibroblast/myofibroblast transition begins with the appearance of the protomyofibroblast, whose stress fibers contain only beta- and gamma-cytoplasmic actins and evolves, but not necessarily always, into the appearance of the differentiated myofibroblast, the most common variant of this cell, with stress fibers containing alpha-smooth muscle actin. Myofibroblast differentiation is a complex process, regulated by at least a cytokine (the transforming growth factor-beta1), an extracellular matrix component (the ED-A splice variant of cellular fibronectin), as well as the presence of mechanical tension. The myofibroblast is a key cell for the connective tissue remodeling that takes place during wound healing and fibrosis development. On this basis, the myofibroblast may represent a new important target for improving the evolution of such diseases as hypertrophic scars, and liver, kidney or pulmonary fibrosis.
After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the fibroblast and the smooth muscle cell, the myofibroblast has been identified both in normal tissues, particularly in locations where there is a necessity of mechanical force development, and in pathological tissues, in relation with hypertrophic scarring, fibromatoses and fibrocontractive diseases as well as in the stroma reaction to epithelial tumors. It is now accepted that fibroblast/myofibroblast transition begins with the appearance of the protomyofibroblast, whose stress fibers contain only beta- and gamma-cytoplasmic actins and evolves, but not necessarily always, into the appearance of the differentiated myofibroblast, the most common variant of this cell, with stress fibers containing alpha-smooth muscle actin. Myofibroblast differentiation is a complex process, regulated by at least a cytokine (the transforming growth factor-beta1), an extracellular matrix component (the ED-A splice variant of cellular fibronectin), as well as the presence of mechanical tension. The myofibroblast is a key cell for the connective tissue remodeling that takes place during wound healing and fibrosis development. On this basis, the myofibroblast may represent a new important target for improving the evolution of such diseases as hypertrophic scars, and liver, kidney or pulmonary fibrosis.
Author GABBIANI GIULIO
DESMOULIERE ALEXIS
CHAPONNIER CHRISTINE
Author_xml – sequence: 1
  givenname: Alexis
  surname: Desmoulière
  fullname: Desmoulière, Alexis
  email: desmouliere@gref.u-bordeaux2.fr
  organization: INSERM E0362, Université Victor Segalen Bordeaux 2,Bordeaux, France. desmouliere@gref.u-bordeaux2.fr
– sequence: 2
  givenname: Christine
  surname: Chaponnier
  fullname: Chaponnier, Christine
– sequence: 3
  givenname: Giulio
  surname: Gabbiani
  fullname: Gabbiani, Giulio
BackLink https://cir.nii.ac.jp/crid/1570854175179577856$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/15659031$$D View this record in MEDLINE/PubMed
BookMark eNo9j0tLxDAcxHNYcR_6FaSCeNrWf5LmdZTFFyx4Wc8lSRPM0qZr04L77a3s6hxmDvNjYJZoFrvoELrFUOBJD_sCAxc5VkQUBIAVmAIGUnzP0OK_maNlSnuYaqbkJZpjxpkCihcI70JKo8t6d9ChX2e2i0Ov7RC6uM50rLPh02XtsfPB9J1pdBqu0IXXTXLX51yhj-en3eY1376_vG0et3kkVA65wUYD4b7Uyk7poFTKejDEkdJxqZxUREHNhOVMa28VZVoJJr1x4LWhdIXuT7uHvvsaXRqqNiTrmkZH142p4oJywLKcwJszOJrW1dWhD63uj9XfyQm4OwExhMqGX8dMgGQlFgwLxYSQjNMfxTpfEQ
ContentType Journal Article
DBID RYH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1067-1927.2005.130102.x
DatabaseName CiNii Complete
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EndPage 12
ExternalDocumentID 15659031
10015459075
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
.3N
.GA
.Y3
04C
05W
0R~
10A
123
1OB
1OC
29R
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOJX
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGQPQ
AGYGG
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECT
ECV
EIHBH
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
ROL
RX1
RYH
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
ABEML
ACSCC
AEUQT
AFPWT
AHEFC
CGR
CUY
CVF
CYRXZ
ECM
EIF
FZ0
HF~
NPM
PALCI
RIWAO
RJQFR
SAMSI
WRC
WUP
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-n238t-b1ba026f4a9c026e0499cf0b2e24e689e89290d57c65aafc935a9758fbe0fab33
ISICitedReferencesCount 732
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000227012700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1067-1927
IngestDate Fri Jul 11 16:41:50 EDT 2025
Wed Feb 19 01:42:44 EST 2025
Thu Jun 26 23:03:20 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-n238t-b1ba026f4a9c026e0499cf0b2e24e689e89290d57c65aafc935a9758fbe0fab33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 15659031
PQID 67360184
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67360184
pubmed_primary_15659031
nii_cinii_1570854175179577856
PublicationCentury 2000
PublicationDate 2005-01-01
2005 Jan-Feb
20050101
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – month: 01
  year: 2005
  text: 2005-01-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Wound repair and regeneration
PublicationTitleAlternate Wound Repair Regen
PublicationTitle_FL Wound Repair Regen
PublicationYear 2005
SSID ssj0005598
Score 2.3585122
SecondaryResourceType review_article
Snippet After the first description of the myofibroblast in granulation tissue of an open wound by means of electron microscopy, as an intermediate cell between the...
SourceID proquest
pubmed
nii
SourceType Aggregation Database
Index Database
Publisher
StartPage 7
SubjectTerms Cell Differentiation - physiology
Cicatrix - physiopathology
Fibroblasts - physiology
Fibrosis - physiopathology
Humans
Myocytes, Smooth Muscle - physiology
Wound Healing - physiology
Wounds and Injuries - physiopathology
Title Tissue repair, contraction, and the myofibroblast
URI https://cir.nii.ac.jp/crid/1570854175179577856
https://www.ncbi.nlm.nih.gov/pubmed/15659031
https://www.proquest.com/docview/67360184
Volume 13
WOSCitedRecordID wos000227012700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  issn: 1067-1927
  databaseCode: DRFUL
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://onlinelibrary.wiley.com
  omitProxy: false
  ssIdentifier: ssj0005598
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwELbKQ6iXqlV5ttAgVT0RKY7ttX2sWqAHtEVoUfcW2V4b5YB3yy4I_j3jx5asaAs99OJETmIr_pLxjOfzDEIfDRtRUlldquAfpBLTUklOSmmYUpoKQ4iLySZ4vy-GQ3mas6JOYzoB7r24vZWT_wo11AHYYevsP8D9q1GogHMAHUqAHcrnAR-HMjgDVBvhiGz0tH9hztUM2ublHXSjQz4ZNV1YoP8RMi3l5xP93F7E4NRdnz3Yq5chmXp0tIvM1Y3BNTuEgcnY-zbvNIxBDDpO_GOlQ7jzSCY4bqGl8cICBOssQCSZCRNeCYoiXxCq5NHHkyQk_7vcnreVVrtgggUFaE7o7MbK7n9vjs5PTprB4XDwafKzDGnEgrs951RZQis1ZxLE3MrXM7jxgfXDZNodmftZQ_sdctfvewe1w7ftn02QqIoMXqNX2YYoPifs36AX1r9FOOFeJNwOig7qBwWgWADmxQLm6-j86HDw5VuZ82GUHhSrWamxVmAyO6qkgaMN1qpxla5tTW1PSCtA161GjJse_GjOSMLgv2PCaVs5pQnZQMt-7O0WKlyNNXHOEMMcHWGjiBTY4LrmShtnettoF165MW0oMeOgmFNQNEF6M84Fg-sf5oPRgDwKTibl7fh6GnmCFRZ0G22mMWomKWwKNNNjEuaQnSeffYdePnxo79Hy7Ora7qJVczNrp1d7aIkPxV4G9h4gr1vO
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tissue+repair%2C+contraction%2C+and+the+myofibroblast&rft.jtitle=Wound+repair+and+regeneration&rft.au=Desmouli%C3%A8re%2C+Alexis&rft.au=Chaponnier%2C+Christine&rft.au=Gabbiani%2C+Giulio&rft.date=2005-01-01&rft.issn=1067-1927&rft.volume=13&rft.issue=1&rft.spage=7&rft_id=info:doi/10.1111%2Fj.1067-1927.2005.130102.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1067-1927&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1067-1927&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1067-1927&client=summon